Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for AZTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.510B
March 31, 2026 1.555B
December 31, 2025 1.715B
September 30, 2025 1.727B
June 30, 2025 1.674B
March 31, 2025 1.701B
December 31, 2024 1.719B
September 30, 2024 1.768B
June 30, 2024 1.990B
March 31, 2024 2.223B
December 31, 2023 2.444B
September 30, 2023 2.534B
June 30, 2023 2.724B
March 31, 2023 2.895B
December 31, 2022 2.871B
September 30, 2022 3.363B
June 30, 2022 3.428B
March 31, 2022 3.465B
December 31, 2021 1.367B
September 30, 2021 1.325B
June 30, 2021 1.308B
March 31, 2021 1.266B
December 31, 2020 1.252B
September 30, 2020 1.214B
June 30, 2020 1.175B
Date Value
March 31, 2020 1.161B
December 31, 2019 1.159B
September 30, 2019 1.139B
June 30, 2019 738.13M
March 31, 2019 729.91M
December 31, 2018 730.20M
September 30, 2018 717.83M
June 30, 2018 712.22M
March 31, 2018 697.83M
December 31, 2017 626.00M
September 30, 2017 607.64M
June 30, 2017 589.77M
March 31, 2017 570.61M
December 31, 2016 552.90M
September 30, 2016 553.69M
June 30, 2016 543.06M
March 31, 2016 537.95M
December 31, 2015 620.23M
September 30, 2015 632.04M
June 30, 2015 631.23M
March 31, 2015 628.83M
December 31, 2014 630.61M
September 30, 2014 642.89M
June 30, 2014 657.34M
March 31, 2014 633.58M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 7.122B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B
Danaher Corp. 52.58B
Harvard Bioscience, Inc. 7.418M

Shareholders Equity (Quarterly) Related Metrics